The mechanism behind BRAF/MEK inhibitor induced panuveitis, which clinically closely resembles the VKH disease, might be related to its interference with the MAPK pathway, which is involved in the T-cell receptor signaling pathway. The gene discussed is BRAF; the disease is Vogt-Koyanagi-Harada disease.